Walgreens Boots Alliance Stock Forecast, Price & News

Walgreens Boots Alliance's stock was trading at $46.07 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, WBA stock has decreased by 21.5% and is now trading at $36.16.
View which stocks have been most impacted by COVID-19.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Walgreens Boots Alliance in the last year. There are currently 1 sell rating and 14 hold ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Walgreens Boots Alliance.

Walgreens Boots Alliance is scheduled to release its next quarterly earnings announcement on Monday, October 26th 2020.
View our earnings forecast for Walgreens Boots Alliance.

Walgreens Boots Alliance Inc (NASDAQ:WBA) posted its quarterly earnings results on Thursday, July, 9th. The pharmacy operator reported $0.83 EPS for the quarter, missing the consensus estimate of $1.10 by $0.27. The pharmacy operator earned $34.63 billion during the quarter, compared to analysts' expectations of $34.32 billion. Walgreens Boots Alliance had a net margin of 0.55% and a return on equity of 19.43%. The company's quarterly revenue was up .1% compared to the same quarter last year. During the same period last year, the company earned $1.47 EPS.
View Walgreens Boots Alliance's earnings history.

Walgreens Boots Alliance announced a quarterly dividend on Thursday, July 9th. Investors of record on Wednesday, August 19th will be given a dividend of $0.4675 per share on Friday, September 11th. This represents a $1.87 dividend on an annualized basis and a yield of 5.17%. The ex-dividend date is Tuesday, August 18th. This is a positive change from Walgreens Boots Alliance's previous quarterly dividend of $0.46.
View Walgreens Boots Alliance's dividend history.

Walgreens Boots Alliance issued an update on its FY20 earnings guidance on Thursday, July, 9th. The company provided earnings per share guidance of $4.65-4.75 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.49.

15 equities research analysts have issued 1-year target prices for Walgreens Boots Alliance's shares. Their forecasts range from $37.00 to $61.00. On average, they anticipate Walgreens Boots Alliance's share price to reach $44.79 in the next twelve months. This suggests a possible upside of 23.9% from the stock's current price.
View analysts' price targets for Walgreens Boots Alliance.

Walgreens Boots Alliance saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 19,040,000 shares, an increase of 8.6% from the August 15th total of 17,540,000 shares. Based on an average trading volume of 6,650,000 shares, the short-interest ratio is currently 2.9 days. Approximately 2.7% of the shares of the company are short sold.
View Walgreens Boots Alliance's Short Interest.

Some companies that are related to Walgreens Boots Alliance include CVS Health (CVS), Covetrus (CVET), Petmed Express (PETS), Rite Aid (RAD), 111 (YI), China Jo-Jo Drugstores (CJJD), HealthWarehouse.com (HEWA), Dougherty's Pharmacy (MYDP) and China Dasheng Biotechnology (CDBT).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Walgreens Boots Alliance investors own include AT&T (T), Intel (INTC), CVS Health (CVS), Johnson & Johnson (JNJ), Walt Disney (DIS), AbbVie (ABBV), Cisco Systems (CSCO), Verizon Communications (VZ), Pfizer (PFE) and Exxon Mobil (Xom).

Walgreens Boots Alliance trades on the NASDAQ under the ticker symbol "WBA."

Walgreens Boots Alliance's stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (7.00%), BlackRock Inc. (6.03%), FMR LLC (1.34%), LSV Asset Management (1.11%), Bank of New York Mellon Corp (0.85%) and Thornburg Investment Management Inc. (0.67%). Company insiders that own Walgreens Boots Alliance stock include Kathleen Wilson-Thompson, Kimberly R Scardino, Marco Patrick Anthony Pagni, Nancy M Schlichting, Ornella Barra and William C Foote.
View institutional ownership trends for Walgreens Boots Alliance.

WBA stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Two Sigma Advisers LP, FMR LLC, Thornburg Investment Management Inc., State of Michigan Retirement System, Rockefeller Capital Management L.P., Cullen Capital Management LLC, and American International Group Inc..
View insider buying and selling activity for Walgreens Boots Alliance.

WBA stock was acquired by a variety of institutional investors in the last quarter, including AQR Capital Management LLC, BlackRock Inc., Nordea Investment Management AB, Unigestion Holding SA, Great West Life Assurance Co. Can, Sumitomo Mitsui Trust Holdings Inc., Prudential Financial Inc., and Mn Services Vermogensbeheer B.V..
View insider buying and selling activity for Walgreens Boots Alliance.

Shares of WBA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of WBA stock can currently be purchased for approximately $36.16.

Walgreens Boots Alliance has a market capitalization of $31.33 billion and generates $136.87 billion in revenue each year. The pharmacy operator earns $3.98 billion in net income (profit) each year or $5.99 on an earnings per share basis. Walgreens Boots Alliance employs 342,000 workers across the globe.

The official website for Walgreens Boots Alliance is www.walgreensbootsalliance.com.

Walgreens Boots Alliance's mailing address is 108 Wilmot Road, Deerfield IL, 60015. The pharmacy operator can be reached via phone at 847-315-2500 or via email at [email protected]